The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from ...

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Any joint can become arthritic, but the most commonly affected areas of the body are the knees, hands, hips, feet and lower back - getty For many of us, aches and pains, sore joints and stiffness are ...

Signs of immune system aging appear years before rheumatoid arthritis takes hold, offering new hope for early diagnosis and ...

Rheumatoid arthritis (RA) impacts thousands of Australians each year, causing pain, stiffness, and a steady decline in strength. As many as 2% of adults face the daily challenges of this condition, ...

Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids (see Corticosteroid Therapy) can be useful for acute pain relief in patients with rheumatoid arthritis (RA). In osteoarthritis, studies have ...

WEDNESDAY, Sept. 10, 2025 (HealthDay News) — Rheumatoid arthritis might be caused in part by a prematurely aging immune ...

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of ...

Everyday movements, like climbing stairs or squatting, are often accompanied by a nagging stiffness that many brushes off as ...

SAN DIEGO, California ― For patients with moderate to severe rheumatoid arthritis whose condition is refractory to methotrexate, pain relief is better with the JAK inhibitor baricitinib than with the ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the medication — and that's been life-changing for Cassandra Smith.

Rheumatoid arthritis (RA) is an autoimmune condition that develops when your immune system attacks healthy cells in your joints. Biological females have about a 3.6% lifetime risk of developing RA, ...